← Back to Clinical Trials
Recruiting NCT06050421

NCT06050421 Radically Open Dialectical Behaviour Therapy in Patients With Anorexia Nervosa

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06050421
Status Recruiting
Phase
Sponsor Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
Condition Anorexia Nervosa
Study Type INTERVENTIONAL
Enrollment 96 participants
Start Date 2023-06-22
Primary Completion 2025-12-31

Eligibility & Interventions

Sex Female only
Min Age 18 Years
Max Age 65 Years
Study Type INTERVENTIONAL
Interventions
Radically Open Dialectical Behaviour Therapy (RO-DBT)Treatment As UsualNo intervention

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 96 participants in total. It began in 2023-06-22 with a primary completion date of 2025-12-31.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Randomized controlled clinical trial to evaluate the efficacy of "Radically Open Dialectical Behaviour Therapy" in patients with eating disorders: a proof-of-concept study.

Eligibility Criteria

Inclusion Criteria: * female patients * aged between 18 to 65 years old, * having a diagnosis of AN (DSM 5 criteria), * having had weigh restoration treatment (normal BMI considered \>19 kg/m2) * having an overcontrol personality style assessed with the styles of coping Word-Pair Checklist scale (ASC-WP) Exclusion Criteria: * diagnosis of severe mental illness (schizophrenia or other psychosis, bipolar disorder, major depressive disorder, substance use disorder) * diagnosis of borderline personality disorder (BPD) or positive result in McLean Screening Instrument for BPD * mental retardation * being under standardized psychotherapy at the baseline * being illiterate or not able to understand Spanish language, * being left-handed * being pregnant for MRI requirements.

Contact & Investigator

Central Contact

Cristina Carmona, Doctor

✉ ccarmonaf@santpau.cat

📞 0034650003427

Principal Investigator

Cristina Carmona

PRINCIPAL INVESTIGATOR

Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau

Frequently Asked Questions

Who can join the NCT06050421 clinical trial?

This trial is open to female participants only, aged 18 Years or older, up to 65 Years, studying Anorexia Nervosa. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06050421 currently recruiting?

Yes, NCT06050421 is actively recruiting participants. Contact the research team at ccarmonaf@santpau.cat for enrollment information.

Where is the NCT06050421 trial being conducted?

This trial is being conducted at Barcelona, Spain.

Who is sponsoring the NCT06050421 clinical trial?

NCT06050421 is sponsored by Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau. The principal investigator is Cristina Carmona at Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau. The trial plans to enroll 96 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology